Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine

Author:

Kudman Sarah12,Semaan Alissa12ORCID,Assaad Majd Al12,Gogineni Swarna1,Martin M. Laura2,Mathew Susan1,Elemento Olivier234,Wilkes David C.12,Mosquera Juan Miguel12

Affiliation:

1. Department of Pathology and Laboratory Medicine Weill Cornell Medicine New York New York

2. Englander Institute for Precision Medicine Weill Cornell Medicine New York New York

3. Department of Physiology and Biophysics Weill Cornell Medicine New York New York

4. Institute for Computational Biomedicine Weill Cornell Medicine New York New York

Abstract

AbstractFluorescence in situ hybridization (FISH) is a cytogenetic assay that is widely used in both clinical and research settings to validate genetic aberrations. Simple in principle, it is based on denaturation and hybridization of a DNA probe and its complementary sequence; however, it is subject to continuous optimization. Here we share how in‐house FISH can be optimized using different control tissues to visualize and ultimately validate common and novel genetic abnormalities unearthed by next‐generation sequencing (NGS). Seven specific FISH probes were designed and labeled, and conditions for eight tissue types and one patient‐derived tumor organoid were optimized. Formalin‐fixed paraffin‐embedded (FFPE) tissue slides were used for each experiment. Slides were first deparaffinized, then placed in a pretreatment solution followed by a digestion step. In‐house FISH probes were then added to the tissue to be denatured and hybridized, and then washed twice. To obtain optimal results, probe concentration, pepsin incubation time, denaturation, and the two post‐hybridization washes were optimized for each sample. By modifying the above conditions, all FISH experiments were optimized in separate tissue types to investigate specific genomic alterations in tumors arising in those tissues. Signals were clear and distinct, allowing for visualization of the selected probes. Following this protocol, our lab has quickly optimized 11 directly labeled in‐house FISH probes to support genetic aberrations nominated by NGS, including most recent discoveries through whole‐genome sequencing analyses. We describe a robust approach of how to advance in‐house labeled FISH probes. By following these guidelines, reliable and reproducible FISH results can be obtained to interrogate FFPE slides from benign, tumor tissues, and patient‐derived tumor organoid specimens. This is of most relevance in the era of NGS and precision oncology. © 2024 Wiley Periodicals LLC.Basic Protocol 1: Metaphase FISH optimizationSupport Protocol 1: In‐house probe labeling and preparationSupport Protocol 2: Metaphase spread preparationBasic Protocol 2: Optimization of FISH on formalin‐fixed paraffin‐embedded tissue

Publisher

Wiley

Reference18 articles.

1. Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets

2. The AGT Cytogenetics Laboratory Manual

3. Cutting sections of paraffin‐embedded tissues;Fischer A. H.;CSH Protocols,2008

4. Paraffin embedding tissue samples for sectioning;Fischer A. H.;CSH Protocols,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3